EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)’s traded shares stood at 1.37 million during the latest session, with the company’s beta value hitting 1.67. At the last check today, the stock’s price was $18.95, to imply a decrease of -9.50% or -$1.99 in intraday trading. The EYPT share’s 52-week high remains $30.99, putting it -63.54% down since that peak but still an impressive 76.52% since price per share fell to its 52-week low of $4.45. The company has a valuation of $944.28M, with an average of 925.92K shares over the past 3 months.

EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) trade information

After registering a -9.50% downside in the latest session, EyePoint Pharmaceuticals Inc (EYPT) has traded red over the past five days. The stock hit a weekly high of 23.65, dropping -9.50% in its intraday price action. The 5-day price performance for the stock is -17.21%, and -14.25% over 30 days. With these gigs, the year-to-date price performance is -18.00%.

EyePoint Pharmaceuticals Inc (EYPT) estimates and forecasts

Looking at statistics comparing EyePoint Pharmaceuticals Inc share performance against respective industry, we note that the company has underperformed competitors. EyePoint Pharmaceuticals Inc (EYPT) shares are 135.70% up over the last 6 months, with its year-to-date growth rate lower than industry average at 4.95% against 13.10%.

EYPT Dividends

EyePoint Pharmaceuticals Inc has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. EyePoint Pharmaceuticals Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.